152536-17-9 Usage
Uses
Used in Pharmaceutical Industry:
6-Quinazolinecarboxylic acid, 4-chloro-, methyl ester is used as a key intermediate in the synthesis of various pharmaceutical drugs. Its unique structure and functional groups enable the development of new therapeutic agents with potential applications in treating cancer and neurological disorders.
Used in Agrochemical Industry:
6-Quinazolinecarboxylic acid, 4-chloro-, methyl ester is used as a building block in the production of agrochemicals, such as pesticides and herbicides. Its ability to modulate biological pathways makes it a promising candidate for the development of novel agrochemicals with improved efficacy and selectivity.
Used in Organic Synthesis:
6-Quinazolinecarboxylic acid, 4-chloro-, methyl ester is used as a valuable building block in organic synthesis. Its chlorine substituent provides an opportunity for further functionalization, allowing the synthesis of a wide range of organic compounds with diverse applications in various industries.
Used in Research and Development:
6-Quinazolinecarboxylic acid, 4-chloro-, methyl ester is used in research and development for the exploration of its potential applications in various fields, such as drug discovery, agrochemical development, and organic synthesis. Its unique structure and functional groups make it an interesting target for scientific investigation and innovation.
Check Digit Verification of cas no
The CAS Registry Mumber 152536-17-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,2,5,3 and 6 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 152536-17:
(8*1)+(7*5)+(6*2)+(5*5)+(4*3)+(3*6)+(2*1)+(1*7)=119
119 % 10 = 9
So 152536-17-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H7ClN2O2/c1-15-10(14)6-2-3-8-7(4-6)9(11)13-5-12-8/h2-5H,1H3
152536-17-9Relevant articles and documents
2-IMINO-4-(THIO) OXO-5-POLY CYCLOVINYLAZOLINES FOR USE AS P13 KINASE IHIBITORS
-
Page 39, (2008/06/13)
The present invention is related to 2-imino-azolinone-vinyl fused-benzene derivatives of Formula (1) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.
AZOLIDINONE-VINYL FUSED-BENZENE DERIVATIVES
-
Page 58, (2008/06/13)
The present invention is related to azolidinedione-vinyl fused-benzene derivatives of formula (I) for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, graft rejection or lung injuries. Formula (I), wherein A, X, Y, Z, R1 , R2 and n are as described in the description.